Discover BioLineRx's Q1 2025 highlights, including APHEXDA growth, cost reductions, pipeline expansion, and updates on oncology trials.

Air France-KLM remains a deep value play with high volatility, yet significant upside potential if its recovery plan succeeds ...

Startups: Learn from Prashasta Seth, CEO of Prudent Investment Managers, about financial discipline, funding choices, and ...

The Norwegian offshore driller Dolphin Drilling has put a difficult period of financial uncertainty behind it with the ...

Nissan aims to raise $7 billion through debt and asset sales with UK government backing as the company aims for a turn around ...

RocketLab is one of just five companies approved to launch for the Department of Defense. Its upcoming Neutron rocket could ...

The last report shows short interest rising compared to the ... extending the company’s financial runway.

This financial move is aimed at extending the company’s cash runway into early 2027, ... falling short of the projected $107.85 million.

Explore the complexities of Buy Now, Pay Later services in South Africa, examining the legal challenges and regulatory ...

BioLine Rx Ltd (BLRX) reports a significant net income turnaround and strategic partnerships despite revenue challenges.

The effects of extreme heat in Europe and the world as temperatures soar, transforming business operations in cities like Dubrovnik.